- Home
- SBH vs ANIP Comparison
SBH vs ANIP Comparison
Compare SBH & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBH
- ANIP
- Stock Information
- Founded
- SBH 1964
- ANIP 2001
- Country
- SBH United States
- ANIP United States
- Employees
- SBH N/A
- ANIP N/A
- Industry
- SBH Other Specialty Stores
- ANIP Biotechnology: Pharmaceutical Preparations
- Sector
- SBH Consumer Discretionary
- ANIP Health Care
- Exchange
- SBH Nasdaq
- ANIP Nasdaq
- Market Cap
- SBH 1.3B
- ANIP 1.2B
- IPO Year
- SBH 2006
- ANIP N/A
- Fundamental
- Price
- SBH $12.27
- ANIP $55.35
- Analyst Decision
- SBH Hold
- ANIP Buy
- Analyst Count
- SBH 5
- ANIP 7
- Target Price
- SBH $13.50
- ANIP $77.33
- AVG Volume (30 Days)
- SBH 2.1M
- ANIP 253.7K
- Earning Date
- SBH 01-30-2025
- ANIP 11-08-2024
- Dividend Yield
- SBH N/A
- ANIP N/A
- EPS Growth
- SBH N/A
- ANIP N/A
- EPS
- SBH 1.43
- ANIP N/A
- Revenue
- SBH $3,717,031,000.00
- ANIP $555,456,000.00
- Revenue This Year
- SBH $2.07
- ANIP $25.49
- Revenue Next Year
- SBH $1.61
- ANIP $19.92
- P/E Ratio
- SBH $8.59
- ANIP N/A
- Revenue Growth
- SBH N/A
- ANIP 23.60
- 52 Week Low
- SBH $9.06
- ANIP $52.00
- 52 Week High
- SBH $14.79
- ANIP $70.81
- Technical
- Relative Strength Index (RSI)
- SBH 38.95
- ANIP 42.29
- Support Level
- SBH $12.17
- ANIP $55.29
- Resistance Level
- SBH $12.63
- ANIP $57.33
- Average True Range (ATR)
- SBH 0.41
- ANIP 1.88
- MACD
- SBH -0.14
- ANIP -0.16
- Stochastic Oscillator
- SBH 9.00
- ANIP 5.34
About SBH Sally Beauty Holdings Inc. (Name to be changed from Sally Holdings Inc.)
Sally Beauty Holdings Inc is a professional beauty-products retailer based in the United States. Sally Beauty operates throughout the United States, Puerto Rico, the United Kingdom, Belgium, Canada, Chile, Colombia, Mexico, Peru, France, Ireland, Spain, Germany, and the Netherlands. The company operates through two business segments: Sally Beauty Supply and Beauty Systems Group. Product offerings include hair color and care, hair dryers and hair-styling appliances, nail care, skin care, and others.
About ANIP ANI Pharmaceuticals Inc.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.